Fig. 1From: Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysisOverall scheme of proteomic analysis. Plasma specimens were collected before and at 6Â weeks after antidepressant treatment in each patient group and healthy individuals. MRM multiple reaction monitoring, MS mass spectrometry, N number of patients, RT retention time, S/N signal-to-noise ratio, TBG thyroxine-binding globulinBack to article page